|
|
||||||||
The Journal of Immunology, Vol 144, Issue 7 2683-2689, Copyright © 1990 by American Association of Immunologists
ARTICLES |
AE Nel, C Hanekom, A Rheeder, K Williams, S Pollack, R Katz and GE Landreth
Department of Medicine, UCLA School of Medicine 90024-1680.
Signaling via the alpha-beta T cell Ag receptor (Ti)-CD3 complex is a complicated event that implicates several protein kinases, most notably protein kinase C (PKC). We have recently identified a serine kinase in T lymphocytes with the following characteristics: molecular mass 43 kDa, in vitro substrate affinity for microtubule associated protein 2 (MAP-2) with a preference for Mn2+ during the catalytic reaction, and elution from DEAE resin over a salt range 100 to 200 mM NaCl. This kinase is activated in a rapidly reversible fashion during ligation of CD3/Ti by a process which involves prior phosphorylation; in vitro exposure of activated 43-kDa MAP-2 kinase (MAP-K) to an immobilized phosphatase abrogated its kinase activity. We now show that a MAP-2K response could also be obtained during treatment with mAb to Ti and the specific PKC agonist, PMA. Although the kinetics of the former response was rapidly reversible, PMA elicited a more prolonged response. The dose responsiveness for PMA was similar to the requirements for PKC activation in intact lymphocytes. Moreover, as with PKC, we found that the CD3-induced MAP-2K response could be further enhanced by using a second layer cross-linking antibody. The specificity of CD3/Ti in the Jurkat cell response is demonstrated by the fact that OKT-11(CD2) and anti-CD4 mAb did not stimulate a MAP-2K response. It was also not possible to elicit a response in a Jurkat cell mutant that lacks surface expression of CD3 and Ti. The specificity of PKC in these events was further explored with the cell permeant diacylglycerol, 1- oleoyl-2-acetylglycerol, and the nonagonist phorbol ester, 4 alpha- phorbol 12,13-didecanoate: whereas the former was an effective inducer of the MAP-2K response, the latter failed to yield any stimulation. Prior exposure of Jurkat cells to 100 mM PMA for 24 h eliminated greater than 60% of the MAP-2K response during anti-CD3 treatment. This response could also be inhibited in dose-dependent fashion by prior treatment of Jurkat cells with the potent PKC inhibitor 1-(5- isoquinolinesulfonyl) 2-methylpiperazine dihydrochloride. Although a Ca2(+)-ionophore failed to synergize with PMA at inducing a MAP-2K response, depletion of extracellular Ca2+ by EGTA abrogated anti-CD3 responsiveness. The events culminating in MAP-2K activation were slightly inhibited in the presence of cholera toxin but not pertussis toxin.(ABSTRACT TRUNCATED AT 400 WORDS)
This article has been cited by other articles:
![]() |
A. Denys, A. Hichami, and N. A. Khan n-3 PUFAs modulate T-cell activation via protein kinase C-{alpha} and -{varepsilon} and the NF-{kappa}B signaling pathway J. Lipid Res., April 1, 2005; 46(4): 752 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Denys, A. Hichami, and N. A. Khan Eicosapentaenoic acid and docosahexaenoic acid modulate MAP kinase (ERK1/ERK2) signaling in human T cells J. Lipid Res., December 1, 2001; 42(12): 2015 - 2020. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsuguchi, K. Takagi, T. Musikacharoen, and Y. Yoshikai Gene expressions of lipopolysaccharide receptors, toll-like receptors 2 and 4, are differently regulated in mouse T lymphocytes Blood, February 15, 2000; 95(4): 1378 - 1385. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Kennedy, A. Sekulic, B. J. Irvin, A. E. Nilson, S. M. Dilworth, and R. T. Abraham Polyomavirus Middle T Antigen as a Probe for T Cell Antigen Receptor-coupled Signaling Pathways J. Biol. Chem., May 8, 1998; 273(19): 11505 - 11513. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Holmstrom, S. C. Chow, I. Elo, E. T. Coffey, S. Orrenius, L. Sistonen, and J. E. Eriksson Suppression of Fas/APO-1-Mediated Apoptosis by Mitogen-Activated Kinase Signaling J. Immunol., March 15, 1998; 160(6): 2626 - 2636. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhao, Y.-Y. Li, R. V. Fucini, S. E. Ross, J. E. Pessin, and G. A. Koretzky T Cell Receptor-induced Phosphorylation of Sos Requires Activity of CD45, Lck, and Protein Kinase C, but Not ERK J. Biol. Chem., August 22, 1997; 272(34): 21625 - 21634. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jascur, J. Gilman, and T. Mustelin Involvement of Phosphatidylinositol 3-Kinase in NFAT Activation in T Cells J. Biol. Chem., May 30, 1997; 272(22): 14483 - 14488. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mege, V. Di Bartolo, V. Germain, L. Tuosto, F. Michel, and O. Acuto Mutation of Tyrosines 492/493 in the Kinase Domain of ZAP-70 Affects Multiple T-cell Receptor Signaling Pathways J. Biol. Chem., December 20, 1996; 271(51): 32644 - 32652. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Butch and K.-L. Guan Characterization of ERK1 Activation Site Mutants and the Effect on Recognition by MEK1 and MEK2 J. Biol. Chem., February 23, 1996; 271(8): 4230 - 4235. [Abstract] [Full Text] [PDF] |
||||
![]() |
AndrE. Nel, S. Gupta, L. Lee, J. A. Ledbetter, and S. B. Kanner Ligation of the T-cell Antigen Receptor (TCR) Induces Association of hSos1, ZAP-70, Phospolipase C-[IMAGE]1, and Other Phosphoproteins with Grb2 and the [IMAGE]-Chain of the TCR J. Biol. Chem., August 4, 1995; 270(31): 18428 - 18436. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-P. Hsueh and M.-Z. Lai c-Jun N-terminal Kinase but Not Mitogen-activated Protein Kinase Is Sensitive to cAMP Inhibition in T Lymphocytes J. Biol. Chem., July 28, 1995; 270(30): 18094 - 18098. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Khalil, C. B. Menice, C.-L. A. Wang, and K. G. Morgan Phosphotyrosine-Dependent Targeting of Mitogen-Activated Protein Kinase in Differentiated Contractile Vascular Cells Circ. Res., June 1, 1995; 76(6): 1101 - 1108. [Abstract] [Full Text] |
||||
![]() |
X. Xu, J. W. Williams, E. G. Bremer, A. Finnegan, and A. S.-F. Chong Inhibition of Protein Tyrosine Phosphorylation in T Cells by a Novel Immunosuppressive Agent, Leflunomide J. Biol. Chem., May 26, 1995; 270(21): 12398 - 12403. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Ettehadieh, J. Sanghera, S. Pelech, D Hess-Bienz, J Watts, N Shastri, and R Aebersold Tyrosyl phosphorylation and activation of MAP kinases by p56lck Science, February 14, 1992; 255(5046): 853 - 855. [Abstract] [PDF] |
||||
![]() |
A. Weiss, A.C. Chan, M. Iwashima, D. Straus, and B.A. Irving Regulation of Protein Tyrosine Kinase Activation by the T-cell Antigen Receptor {zeta} Chain Cold Spring Harb Symp Quant Biol, January 1, 1992; 57(0): 107 - 116. [Abstract] [PDF] |
||||
![]() |
A. Alonso, M. Saxena, S. Williams, and T. Mustelin Inhibitory Role for Dual Specificity Phosphatase VHR in T Cell Antigen Receptor and CD28-induced Erk and Jnk Activation J. Biol. Chem., February 9, 2001; 276(7): 4766 - 4771. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |